If you suffer from PSVT episodes and are interested in using a study drug, you may qualify for the PSVT study.
PSVT (Paroxysmal Supraventricular Tachycardia) affects approximately 2 million Americans. Some of the most commonly reported symptoms include rapid heartbeats, sweating, chest pressure or pain, shortness of breath, tiredness, and anxiety.
We’re investigating a study drug (portable nasal spray) that may be able to help stop a PSVT episode.
You may be able to qualify for the PSVT study if you:
- Are 18 years or older
- Have been diagnosed with PSVT
*Other criteria may apply
Prime Revival Research Institute is conducting clinical research trials on a potential PSVT treatment i.e. nasal spray, to observe its safety and efficacy when administered to people suffering from PSVT. The purpose of the PSVT study is to determine whether the investigational drug is effective in stopping a PSVT episode.
*Participation in the PSVT clinical trial is free of cost to both you and your insurance. To see if you qualify for the study, please fill the form. Someone from our research staff will give you a phone call and they might ask you questions about your medical history and information about any medications you take.
**If you qualify and decide to participate, you will receive study-related care from experienced healthcare professionals including Cardiologists and nurses.